Pediatrics

The authors urge that screening, prevention, and treatment of anxiety and depression should be important health care priorities for youth who have chronic pain.

NS-050/NCNP-03 is being developed to aid individuals with confirmed gene mutations that are treatable with exon 50 skipping therapy.

Surprisingly, those with overweight BMI at diagnosis did not have a poor prognosis.

Pediatric patients weighing 20 kg to <50 kg should take 20 mg of apremilast twice daily and children weighing at least 50 kg should take 30 mg twice daily.

Pharmacists can help caregivers by recommending a healthy balanced diet containing high vitamin D intake and supplementation when needed.

Remind parents that routine exams, immunizations, and nutrition are crucial to helping children succeed.

The commencement of the phase 1 clinical trial of SAT-3247 is expected in Q3 of 2024.

The FDA also granted rare pediatric disease designation for the drug.

Immunization rates have not returned to pre-pandemic levels, leaving millions of children and infants at risk for measles or diphtheria, tetanus, and pertussis.

The approval marks the first oral immunotherapy treatment to mitigate allergic reactions, including anaphylaxis.

The molecule can be a potential treatment that counters effects of early-life antibiotics, which can impact the gut microbiota and increase the risk of childhood atopy and asthma.

In April 2017, the drug was approved to treat the slow loss of the ability to walk for symptomatic patients aged 3 and older who had Batten disease.

The authors emphasize that clinical research should focus on real-world difficulties, and pediatric asthma control should be seen as a health care priority.

Unique gut flora were found in children with autism spectrum disorder (ASD).

The authors emphasize that these findings suggest a need for targeted resources that help reduce boarding and promote equitable access to care.

Higher vaccination rates were associated with less prevalent asthmatic symptoms, but additional research is needed to confirm these findings.

In 2 different dose groups, the majority of patients with eosinophilic esophagitis aged 1 to 11 achieved histologic remission at week 16 compared with patients treated with placebo.

However, more research is needed to effectively integrate this biomarker into individualized asthma management strategies for pediatric patients.

The findings show that the largest gaps are among pediatric patients with persistent asthma.

Autism spectrum disorder was also evaluated in the analysis, but further research is required to determine a possible association with relative age effect.

Secondhand exposure to e-cigarette smoke may increase risk of pediatric atopic dermatitis in children.

The study results also found that exposure to tree canopy area may protect children from asthma development; however, efficacy decreased as weed pollen exposure increased.

Trametinib may become an alternative treatment to hematopoietic stem cell transplantation in patients with relapsed or refractory juvenile myelomonocytic leukemia (JMML).

The indication is for the improvement of glycemic control in pediatric patients aged 10 and older with type 2 diabetes and comes after positive results from the phase 3 T2NOW clinical trial.

Parents and caregivers sometimes have concerns about their children receiving these injections, but researchers and experts assure that the FDA-approved biologic is safe and effective in young populations.

Polyarticular juvenile idiopathic arthritis is a form of arthritis that affects multiple joints at one time.

The authors noted that these networks have a significant role in intellectual ability, physical coordination, working memory, emotional processing, and overall mental health.

Approximately 40% of caregivers make dosing errors when administering liquid medication to children.